Global New Drug Modeling Solution Market Research Report 2024(Status and Outlook)
Report Overview
This report provides a deep insight into the global New Drug Modeling Solution market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global New Drug Modeling Solution Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the New Drug Modeling Solution market in any manner.
Global New Drug Modeling Solution Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
JSR Corporation(Crown Bioscience)
Chemical Computing Group ULC
Nimbus Therapeutics
schrodinger, Inc
Genedata AG
Biognos AB
Compugen Ltd
Dassault Systemes
Acellera
lnstem(Leadscope)
Market Segmentation (by Type)
Database
Software
Others
Market Segmentation (by Application)
Drug Discovery and Development
Computational Physiological Medicine
Disease Modeling
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the New Drug Modeling Solution Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
This report provides a deep insight into the global New Drug Modeling Solution market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global New Drug Modeling Solution Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the New Drug Modeling Solution market in any manner.
Global New Drug Modeling Solution Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
JSR Corporation(Crown Bioscience)
Chemical Computing Group ULC
Nimbus Therapeutics
schrodinger, Inc
Genedata AG
Biognos AB
Compugen Ltd
Dassault Systemes
Acellera
lnstem(Leadscope)
Market Segmentation (by Type)
Database
Software
Others
Market Segmentation (by Application)
Drug Discovery and Development
Computational Physiological Medicine
Disease Modeling
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the New Drug Modeling Solution Market
- Overview of the regional outlook of the New Drug Modeling Solution Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the New Drug Modeling Solution Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of New Drug Modeling Solution
1.2 Key Market Segments
1.2.1 New Drug Modeling Solution Segment by Type
1.2.2 New Drug Modeling Solution Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NEW DRUG MODELING SOLUTION MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NEW DRUG MODELING SOLUTION MARKET COMPETITIVE LANDSCAPE
3.1 Global New Drug Modeling Solution Revenue Market Share by Company (2019-2024)
3.2 New Drug Modeling Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company New Drug Modeling Solution Market Size Sites, Area Served, Product Type
3.4 New Drug Modeling Solution Market Competitive Situation and Trends
3.4.1 New Drug Modeling Solution Market Concentration Rate
3.4.2 Global 5 and 10 Largest New Drug Modeling Solution Players Market Share by Revenue
3.4.3 Mergers & Acquisitions, Expansion
4 NEW DRUG MODELING SOLUTION VALUE CHAIN ANALYSIS
4.1 New Drug Modeling Solution Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NEW DRUG MODELING SOLUTION MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 Mergers & Acquisitions
5.5.2 Expansions
5.5.3 Collaboration/Supply Contracts
5.6 Industry Policies
6 NEW DRUG MODELING SOLUTION MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global New Drug Modeling Solution Market Size Market Share by Type (2019-2024)
6.3 Global New Drug Modeling Solution Market Size Growth Rate by Type (2019-2024)
7 NEW DRUG MODELING SOLUTION MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global New Drug Modeling Solution Market Size (M USD) by Application (2019-2024)
7.3 Global New Drug Modeling Solution Market Size Growth Rate by Application (2019-2024)
8 NEW DRUG MODELING SOLUTION MARKET SEGMENTATION BY REGION
8.1 Global New Drug Modeling Solution Market Size by Region
8.1.1 Global New Drug Modeling Solution Market Size by Region
8.1.2 Global New Drug Modeling Solution Market Size Market Share by Region
8.2 North America
8.2.1 North America New Drug Modeling Solution Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe New Drug Modeling Solution Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific New Drug Modeling Solution Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America New Drug Modeling Solution Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa New Drug Modeling Solution Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 JSR Corporation(Crown Bioscience)
9.1.1 JSR Corporation(Crown Bioscience) New Drug Modeling Solution Basic Information
9.1.2 JSR Corporation(Crown Bioscience) New Drug Modeling Solution Product Overview
9.1.3 JSR Corporation(Crown Bioscience) New Drug Modeling Solution Product Market Performance
9.1.4 JSR Corporation(Crown Bioscience) New Drug Modeling Solution SWOT Analysis
9.1.5 JSR Corporation(Crown Bioscience) Business Overview
9.1.6 JSR Corporation(Crown Bioscience) Recent Developments
9.2 Chemical Computing Group ULC
9.2.1 Chemical Computing Group ULC New Drug Modeling Solution Basic Information
9.2.2 Chemical Computing Group ULC New Drug Modeling Solution Product Overview
9.2.3 Chemical Computing Group ULC New Drug Modeling Solution Product Market Performance
9.2.4 JSR Corporation(Crown Bioscience) New Drug Modeling Solution SWOT Analysis
9.2.5 Chemical Computing Group ULC Business Overview
9.2.6 Chemical Computing Group ULC Recent Developments
9.3 Nimbus Therapeutics
9.3.1 Nimbus Therapeutics New Drug Modeling Solution Basic Information
9.3.2 Nimbus Therapeutics New Drug Modeling Solution Product Overview
9.3.3 Nimbus Therapeutics New Drug Modeling Solution Product Market Performance
9.3.4 JSR Corporation(Crown Bioscience) New Drug Modeling Solution SWOT Analysis
9.3.5 Nimbus Therapeutics Business Overview
9.3.6 Nimbus Therapeutics Recent Developments
9.4 schrodinger, Inc
9.4.1 schrodinger, Inc New Drug Modeling Solution Basic Information
9.4.2 schrodinger, Inc New Drug Modeling Solution Product Overview
9.4.3 schrodinger, Inc New Drug Modeling Solution Product Market Performance
9.4.4 schrodinger, Inc Business Overview
9.4.5 schrodinger, Inc Recent Developments
9.5 Genedata AG
9.5.1 Genedata AG New Drug Modeling Solution Basic Information
9.5.2 Genedata AG New Drug Modeling Solution Product Overview
9.5.3 Genedata AG New Drug Modeling Solution Product Market Performance
9.5.4 Genedata AG Business Overview
9.5.5 Genedata AG Recent Developments
9.6 Biognos AB
9.6.1 Biognos AB New Drug Modeling Solution Basic Information
9.6.2 Biognos AB New Drug Modeling Solution Product Overview
9.6.3 Biognos AB New Drug Modeling Solution Product Market Performance
9.6.4 Biognos AB Business Overview
9.6.5 Biognos AB Recent Developments
9.7 Compugen Ltd
9.7.1 Compugen Ltd New Drug Modeling Solution Basic Information
9.7.2 Compugen Ltd New Drug Modeling Solution Product Overview
9.7.3 Compugen Ltd New Drug Modeling Solution Product Market Performance
9.7.4 Compugen Ltd Business Overview
9.7.5 Compugen Ltd Recent Developments
9.8 Dassault Systemes
9.8.1 Dassault Systemes New Drug Modeling Solution Basic Information
9.8.2 Dassault Systemes New Drug Modeling Solution Product Overview
9.8.3 Dassault Systemes New Drug Modeling Solution Product Market Performance
9.8.4 Dassault Systemes Business Overview
9.8.5 Dassault Systemes Recent Developments
9.9 Acellera
9.9.1 Acellera New Drug Modeling Solution Basic Information
9.9.2 Acellera New Drug Modeling Solution Product Overview
9.9.3 Acellera New Drug Modeling Solution Product Market Performance
9.9.4 Acellera Business Overview
9.9.5 Acellera Recent Developments
9.10 lnstem(Leadscope)
9.10.1 lnstem(Leadscope) New Drug Modeling Solution Basic Information
9.10.2 lnstem(Leadscope) New Drug Modeling Solution Product Overview
9.10.3 lnstem(Leadscope) New Drug Modeling Solution Product Market Performance
9.10.4 lnstem(Leadscope) Business Overview
9.10.5 lnstem(Leadscope) Recent Developments
10 NEW DRUG MODELING SOLUTION REGIONAL MARKET FORECAST
10.1 Global New Drug Modeling Solution Market Size Forecast
10.2 Global New Drug Modeling Solution Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe New Drug Modeling Solution Market Size Forecast by Country
10.2.3 Asia Pacific New Drug Modeling Solution Market Size Forecast by Region
10.2.4 South America New Drug Modeling Solution Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of New Drug Modeling Solution by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global New Drug Modeling Solution Market Forecast by Type (2025-2030)
11.2 Global New Drug Modeling Solution Market Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of New Drug Modeling Solution
1.2 Key Market Segments
1.2.1 New Drug Modeling Solution Segment by Type
1.2.2 New Drug Modeling Solution Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NEW DRUG MODELING SOLUTION MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NEW DRUG MODELING SOLUTION MARKET COMPETITIVE LANDSCAPE
3.1 Global New Drug Modeling Solution Revenue Market Share by Company (2019-2024)
3.2 New Drug Modeling Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company New Drug Modeling Solution Market Size Sites, Area Served, Product Type
3.4 New Drug Modeling Solution Market Competitive Situation and Trends
3.4.1 New Drug Modeling Solution Market Concentration Rate
3.4.2 Global 5 and 10 Largest New Drug Modeling Solution Players Market Share by Revenue
3.4.3 Mergers & Acquisitions, Expansion
4 NEW DRUG MODELING SOLUTION VALUE CHAIN ANALYSIS
4.1 New Drug Modeling Solution Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NEW DRUG MODELING SOLUTION MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 Mergers & Acquisitions
5.5.2 Expansions
5.5.3 Collaboration/Supply Contracts
5.6 Industry Policies
6 NEW DRUG MODELING SOLUTION MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global New Drug Modeling Solution Market Size Market Share by Type (2019-2024)
6.3 Global New Drug Modeling Solution Market Size Growth Rate by Type (2019-2024)
7 NEW DRUG MODELING SOLUTION MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global New Drug Modeling Solution Market Size (M USD) by Application (2019-2024)
7.3 Global New Drug Modeling Solution Market Size Growth Rate by Application (2019-2024)
8 NEW DRUG MODELING SOLUTION MARKET SEGMENTATION BY REGION
8.1 Global New Drug Modeling Solution Market Size by Region
8.1.1 Global New Drug Modeling Solution Market Size by Region
8.1.2 Global New Drug Modeling Solution Market Size Market Share by Region
8.2 North America
8.2.1 North America New Drug Modeling Solution Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe New Drug Modeling Solution Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific New Drug Modeling Solution Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America New Drug Modeling Solution Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa New Drug Modeling Solution Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 JSR Corporation(Crown Bioscience)
9.1.1 JSR Corporation(Crown Bioscience) New Drug Modeling Solution Basic Information
9.1.2 JSR Corporation(Crown Bioscience) New Drug Modeling Solution Product Overview
9.1.3 JSR Corporation(Crown Bioscience) New Drug Modeling Solution Product Market Performance
9.1.4 JSR Corporation(Crown Bioscience) New Drug Modeling Solution SWOT Analysis
9.1.5 JSR Corporation(Crown Bioscience) Business Overview
9.1.6 JSR Corporation(Crown Bioscience) Recent Developments
9.2 Chemical Computing Group ULC
9.2.1 Chemical Computing Group ULC New Drug Modeling Solution Basic Information
9.2.2 Chemical Computing Group ULC New Drug Modeling Solution Product Overview
9.2.3 Chemical Computing Group ULC New Drug Modeling Solution Product Market Performance
9.2.4 JSR Corporation(Crown Bioscience) New Drug Modeling Solution SWOT Analysis
9.2.5 Chemical Computing Group ULC Business Overview
9.2.6 Chemical Computing Group ULC Recent Developments
9.3 Nimbus Therapeutics
9.3.1 Nimbus Therapeutics New Drug Modeling Solution Basic Information
9.3.2 Nimbus Therapeutics New Drug Modeling Solution Product Overview
9.3.3 Nimbus Therapeutics New Drug Modeling Solution Product Market Performance
9.3.4 JSR Corporation(Crown Bioscience) New Drug Modeling Solution SWOT Analysis
9.3.5 Nimbus Therapeutics Business Overview
9.3.6 Nimbus Therapeutics Recent Developments
9.4 schrodinger, Inc
9.4.1 schrodinger, Inc New Drug Modeling Solution Basic Information
9.4.2 schrodinger, Inc New Drug Modeling Solution Product Overview
9.4.3 schrodinger, Inc New Drug Modeling Solution Product Market Performance
9.4.4 schrodinger, Inc Business Overview
9.4.5 schrodinger, Inc Recent Developments
9.5 Genedata AG
9.5.1 Genedata AG New Drug Modeling Solution Basic Information
9.5.2 Genedata AG New Drug Modeling Solution Product Overview
9.5.3 Genedata AG New Drug Modeling Solution Product Market Performance
9.5.4 Genedata AG Business Overview
9.5.5 Genedata AG Recent Developments
9.6 Biognos AB
9.6.1 Biognos AB New Drug Modeling Solution Basic Information
9.6.2 Biognos AB New Drug Modeling Solution Product Overview
9.6.3 Biognos AB New Drug Modeling Solution Product Market Performance
9.6.4 Biognos AB Business Overview
9.6.5 Biognos AB Recent Developments
9.7 Compugen Ltd
9.7.1 Compugen Ltd New Drug Modeling Solution Basic Information
9.7.2 Compugen Ltd New Drug Modeling Solution Product Overview
9.7.3 Compugen Ltd New Drug Modeling Solution Product Market Performance
9.7.4 Compugen Ltd Business Overview
9.7.5 Compugen Ltd Recent Developments
9.8 Dassault Systemes
9.8.1 Dassault Systemes New Drug Modeling Solution Basic Information
9.8.2 Dassault Systemes New Drug Modeling Solution Product Overview
9.8.3 Dassault Systemes New Drug Modeling Solution Product Market Performance
9.8.4 Dassault Systemes Business Overview
9.8.5 Dassault Systemes Recent Developments
9.9 Acellera
9.9.1 Acellera New Drug Modeling Solution Basic Information
9.9.2 Acellera New Drug Modeling Solution Product Overview
9.9.3 Acellera New Drug Modeling Solution Product Market Performance
9.9.4 Acellera Business Overview
9.9.5 Acellera Recent Developments
9.10 lnstem(Leadscope)
9.10.1 lnstem(Leadscope) New Drug Modeling Solution Basic Information
9.10.2 lnstem(Leadscope) New Drug Modeling Solution Product Overview
9.10.3 lnstem(Leadscope) New Drug Modeling Solution Product Market Performance
9.10.4 lnstem(Leadscope) Business Overview
9.10.5 lnstem(Leadscope) Recent Developments
10 NEW DRUG MODELING SOLUTION REGIONAL MARKET FORECAST
10.1 Global New Drug Modeling Solution Market Size Forecast
10.2 Global New Drug Modeling Solution Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe New Drug Modeling Solution Market Size Forecast by Country
10.2.3 Asia Pacific New Drug Modeling Solution Market Size Forecast by Region
10.2.4 South America New Drug Modeling Solution Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of New Drug Modeling Solution by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global New Drug Modeling Solution Market Forecast by Type (2025-2030)
11.2 Global New Drug Modeling Solution Market Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. New Drug Modeling Solution Market Size Comparison by Region (M USD)
Table 5. Global New Drug Modeling Solution Revenue (M USD) by Company (2019-2024)
Table 6. Global New Drug Modeling Solution Revenue Share by Company (2019-2024)
Table 7. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in New Drug Modeling Solution as of 2022)
Table 8. Company New Drug Modeling Solution Market Size Sites and Area Served
Table 9. Company New Drug Modeling Solution Product Type
Table 10. Global New Drug Modeling Solution Company Market Concentration Ratio (CR5 and HHI)
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. Value Chain Map of New Drug Modeling Solution
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. New Drug Modeling Solution Market Challenges
Table 18. Global New Drug Modeling Solution Market Size by Type (M USD)
Table 19. Global New Drug Modeling Solution Market Size (M USD) by Type (2019-2024)
Table 20. Global New Drug Modeling Solution Market Size Share by Type (2019-2024)
Table 21. Global New Drug Modeling Solution Market Size Growth Rate by Type (2019-2024)
Table 22. Global New Drug Modeling Solution Market Size by Application
Table 23. Global New Drug Modeling Solution Market Size by Application (2019-2024) & (M USD)
Table 24. Global New Drug Modeling Solution Market Share by Application (2019-2024)
Table 25. Global New Drug Modeling Solution Market Size Growth Rate by Application (2019-2024)
Table 26. Global New Drug Modeling Solution Market Size by Region (2019-2024) & (M USD)
Table 27. Global New Drug Modeling Solution Market Size Market Share by Region (2019-2024)
Table 28. North America New Drug Modeling Solution Market Size by Country (2019-2024) & (M USD)
Table 29. Europe New Drug Modeling Solution Market Size by Country (2019-2024) & (M USD)
Table 30. Asia Pacific New Drug Modeling Solution Market Size by Region (2019-2024) & (M USD)
Table 31. South America New Drug Modeling Solution Market Size by Country (2019-2024) & (M USD)
Table 32. Middle East and Africa New Drug Modeling Solution Market Size by Region (2019-2024) & (M USD)
Table 33. JSR Corporation(Crown Bioscience) New Drug Modeling Solution Basic Information
Table 34. JSR Corporation(Crown Bioscience) New Drug Modeling Solution Product Overview
Table 35. JSR Corporation(Crown Bioscience) New Drug Modeling Solution Revenue (M USD) and Gross Margin (2019-2024)
Table 36. JSR Corporation(Crown Bioscience) New Drug Modeling Solution SWOT Analysis
Table 37. JSR Corporation(Crown Bioscience) Business Overview
Table 38. JSR Corporation(Crown Bioscience) Recent Developments
Table 39. Chemical Computing Group ULC New Drug Modeling Solution Basic Information
Table 40. Chemical Computing Group ULC New Drug Modeling Solution Product Overview
Table 41. Chemical Computing Group ULC New Drug Modeling Solution Revenue (M USD) and Gross Margin (2019-2024)
Table 42. JSR Corporation(Crown Bioscience) New Drug Modeling Solution SWOT Analysis
Table 43. Chemical Computing Group ULC Business Overview
Table 44. Chemical Computing Group ULC Recent Developments
Table 45. Nimbus Therapeutics New Drug Modeling Solution Basic Information
Table 46. Nimbus Therapeutics New Drug Modeling Solution Product Overview
Table 47. Nimbus Therapeutics New Drug Modeling Solution Revenue (M USD) and Gross Margin (2019-2024)
Table 48. JSR Corporation(Crown Bioscience) New Drug Modeling Solution SWOT Analysis
Table 49. Nimbus Therapeutics Business Overview
Table 50. Nimbus Therapeutics Recent Developments
Table 51. schrodinger, Inc New Drug Modeling Solution Basic Information
Table 52. schrodinger, Inc New Drug Modeling Solution Product Overview
Table 53. schrodinger, Inc New Drug Modeling Solution Revenue (M USD) and Gross Margin (2019-2024)
Table 54. schrodinger, Inc Business Overview
Table 55. schrodinger, Inc Recent Developments
Table 56. Genedata AG New Drug Modeling Solution Basic Information
Table 57. Genedata AG New Drug Modeling Solution Product Overview
Table 58. Genedata AG New Drug Modeling Solution Revenue (M USD) and Gross Margin (2019-2024)
Table 59. Genedata AG Business Overview
Table 60. Genedata AG Recent Developments
Table 61. Biognos AB New Drug Modeling Solution Basic Information
Table 62. Biognos AB New Drug Modeling Solution Product Overview
Table 63. Biognos AB New Drug Modeling Solution Revenue (M USD) and Gross Margin (2019-2024)
Table 64. Biognos AB Business Overview
Table 65. Biognos AB Recent Developments
Table 66. Compugen Ltd New Drug Modeling Solution Basic Information
Table 67. Compugen Ltd New Drug Modeling Solution Product Overview
Table 68. Compugen Ltd New Drug Modeling Solution Revenue (M USD) and Gross Margin (2019-2024)
Table 69. Compugen Ltd Business Overview
Table 70. Compugen Ltd Recent Developments
Table 71. Dassault Systemes New Drug Modeling Solution Basic Information
Table 72. Dassault Systemes New Drug Modeling Solution Product Overview
Table 73. Dassault Systemes New Drug Modeling Solution Revenue (M USD) and Gross Margin (2019-2024)
Table 74. Dassault Systemes Business Overview
Table 75. Dassault Systemes Recent Developments
Table 76. Acellera New Drug Modeling Solution Basic Information
Table 77. Acellera New Drug Modeling Solution Product Overview
Table 78. Acellera New Drug Modeling Solution Revenue (M USD) and Gross Margin (2019-2024)
Table 79. Acellera Business Overview
Table 80. Acellera Recent Developments
Table 81. lnstem(Leadscope) New Drug Modeling Solution Basic Information
Table 82. lnstem(Leadscope) New Drug Modeling Solution Product Overview
Table 83. lnstem(Leadscope) New Drug Modeling Solution Revenue (M USD) and Gross Margin (2019-2024)
Table 84. lnstem(Leadscope) Business Overview
Table 85. lnstem(Leadscope) Recent Developments
Table 86. Global New Drug Modeling Solution Market Size Forecast by Region (2025-2030) & (M USD)
Table 87. North America New Drug Modeling Solution Market Size Forecast by Country (2025-2030) & (M USD)
Table 88. Europe New Drug Modeling Solution Market Size Forecast by Country (2025-2030) & (M USD)
Table 89. Asia Pacific New Drug Modeling Solution Market Size Forecast by Region (2025-2030) & (M USD)
Table 90. South America New Drug Modeling Solution Market Size Forecast by Country (2025-2030) & (M USD)
Table 91. Middle East and Africa New Drug Modeling Solution Market Size Forecast by Country (2025-2030) & (M USD)
Table 92. Global New Drug Modeling Solution Market Size Forecast by Type (2025-2030) & (M USD)
Table 93. Global New Drug Modeling Solution Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. New Drug Modeling Solution Market Size Comparison by Region (M USD)
Table 5. Global New Drug Modeling Solution Revenue (M USD) by Company (2019-2024)
Table 6. Global New Drug Modeling Solution Revenue Share by Company (2019-2024)
Table 7. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in New Drug Modeling Solution as of 2022)
Table 8. Company New Drug Modeling Solution Market Size Sites and Area Served
Table 9. Company New Drug Modeling Solution Product Type
Table 10. Global New Drug Modeling Solution Company Market Concentration Ratio (CR5 and HHI)
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. Value Chain Map of New Drug Modeling Solution
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. New Drug Modeling Solution Market Challenges
Table 18. Global New Drug Modeling Solution Market Size by Type (M USD)
Table 19. Global New Drug Modeling Solution Market Size (M USD) by Type (2019-2024)
Table 20. Global New Drug Modeling Solution Market Size Share by Type (2019-2024)
Table 21. Global New Drug Modeling Solution Market Size Growth Rate by Type (2019-2024)
Table 22. Global New Drug Modeling Solution Market Size by Application
Table 23. Global New Drug Modeling Solution Market Size by Application (2019-2024) & (M USD)
Table 24. Global New Drug Modeling Solution Market Share by Application (2019-2024)
Table 25. Global New Drug Modeling Solution Market Size Growth Rate by Application (2019-2024)
Table 26. Global New Drug Modeling Solution Market Size by Region (2019-2024) & (M USD)
Table 27. Global New Drug Modeling Solution Market Size Market Share by Region (2019-2024)
Table 28. North America New Drug Modeling Solution Market Size by Country (2019-2024) & (M USD)
Table 29. Europe New Drug Modeling Solution Market Size by Country (2019-2024) & (M USD)
Table 30. Asia Pacific New Drug Modeling Solution Market Size by Region (2019-2024) & (M USD)
Table 31. South America New Drug Modeling Solution Market Size by Country (2019-2024) & (M USD)
Table 32. Middle East and Africa New Drug Modeling Solution Market Size by Region (2019-2024) & (M USD)
Table 33. JSR Corporation(Crown Bioscience) New Drug Modeling Solution Basic Information
Table 34. JSR Corporation(Crown Bioscience) New Drug Modeling Solution Product Overview
Table 35. JSR Corporation(Crown Bioscience) New Drug Modeling Solution Revenue (M USD) and Gross Margin (2019-2024)
Table 36. JSR Corporation(Crown Bioscience) New Drug Modeling Solution SWOT Analysis
Table 37. JSR Corporation(Crown Bioscience) Business Overview
Table 38. JSR Corporation(Crown Bioscience) Recent Developments
Table 39. Chemical Computing Group ULC New Drug Modeling Solution Basic Information
Table 40. Chemical Computing Group ULC New Drug Modeling Solution Product Overview
Table 41. Chemical Computing Group ULC New Drug Modeling Solution Revenue (M USD) and Gross Margin (2019-2024)
Table 42. JSR Corporation(Crown Bioscience) New Drug Modeling Solution SWOT Analysis
Table 43. Chemical Computing Group ULC Business Overview
Table 44. Chemical Computing Group ULC Recent Developments
Table 45. Nimbus Therapeutics New Drug Modeling Solution Basic Information
Table 46. Nimbus Therapeutics New Drug Modeling Solution Product Overview
Table 47. Nimbus Therapeutics New Drug Modeling Solution Revenue (M USD) and Gross Margin (2019-2024)
Table 48. JSR Corporation(Crown Bioscience) New Drug Modeling Solution SWOT Analysis
Table 49. Nimbus Therapeutics Business Overview
Table 50. Nimbus Therapeutics Recent Developments
Table 51. schrodinger, Inc New Drug Modeling Solution Basic Information
Table 52. schrodinger, Inc New Drug Modeling Solution Product Overview
Table 53. schrodinger, Inc New Drug Modeling Solution Revenue (M USD) and Gross Margin (2019-2024)
Table 54. schrodinger, Inc Business Overview
Table 55. schrodinger, Inc Recent Developments
Table 56. Genedata AG New Drug Modeling Solution Basic Information
Table 57. Genedata AG New Drug Modeling Solution Product Overview
Table 58. Genedata AG New Drug Modeling Solution Revenue (M USD) and Gross Margin (2019-2024)
Table 59. Genedata AG Business Overview
Table 60. Genedata AG Recent Developments
Table 61. Biognos AB New Drug Modeling Solution Basic Information
Table 62. Biognos AB New Drug Modeling Solution Product Overview
Table 63. Biognos AB New Drug Modeling Solution Revenue (M USD) and Gross Margin (2019-2024)
Table 64. Biognos AB Business Overview
Table 65. Biognos AB Recent Developments
Table 66. Compugen Ltd New Drug Modeling Solution Basic Information
Table 67. Compugen Ltd New Drug Modeling Solution Product Overview
Table 68. Compugen Ltd New Drug Modeling Solution Revenue (M USD) and Gross Margin (2019-2024)
Table 69. Compugen Ltd Business Overview
Table 70. Compugen Ltd Recent Developments
Table 71. Dassault Systemes New Drug Modeling Solution Basic Information
Table 72. Dassault Systemes New Drug Modeling Solution Product Overview
Table 73. Dassault Systemes New Drug Modeling Solution Revenue (M USD) and Gross Margin (2019-2024)
Table 74. Dassault Systemes Business Overview
Table 75. Dassault Systemes Recent Developments
Table 76. Acellera New Drug Modeling Solution Basic Information
Table 77. Acellera New Drug Modeling Solution Product Overview
Table 78. Acellera New Drug Modeling Solution Revenue (M USD) and Gross Margin (2019-2024)
Table 79. Acellera Business Overview
Table 80. Acellera Recent Developments
Table 81. lnstem(Leadscope) New Drug Modeling Solution Basic Information
Table 82. lnstem(Leadscope) New Drug Modeling Solution Product Overview
Table 83. lnstem(Leadscope) New Drug Modeling Solution Revenue (M USD) and Gross Margin (2019-2024)
Table 84. lnstem(Leadscope) Business Overview
Table 85. lnstem(Leadscope) Recent Developments
Table 86. Global New Drug Modeling Solution Market Size Forecast by Region (2025-2030) & (M USD)
Table 87. North America New Drug Modeling Solution Market Size Forecast by Country (2025-2030) & (M USD)
Table 88. Europe New Drug Modeling Solution Market Size Forecast by Country (2025-2030) & (M USD)
Table 89. Asia Pacific New Drug Modeling Solution Market Size Forecast by Region (2025-2030) & (M USD)
Table 90. South America New Drug Modeling Solution Market Size Forecast by Country (2025-2030) & (M USD)
Table 91. Middle East and Africa New Drug Modeling Solution Market Size Forecast by Country (2025-2030) & (M USD)
Table 92. Global New Drug Modeling Solution Market Size Forecast by Type (2025-2030) & (M USD)
Table 93. Global New Drug Modeling Solution Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Industrial Chain of New Drug Modeling Solution
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global New Drug Modeling Solution Market Size (M USD), 2019-2030
Figure 5. Global New Drug Modeling Solution Market Size (M USD) (2019-2030)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. New Drug Modeling Solution Market Size by Country (M USD)
Figure 10. Global New Drug Modeling Solution Revenue Share by Company in 2023
Figure 11. New Drug Modeling Solution Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 12. The Global 5 and 10 Largest Players: Market Share by New Drug Modeling Solution Revenue in 2023
Figure 13. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 14. Global New Drug Modeling Solution Market Share by Type
Figure 15. Market Size Share of New Drug Modeling Solution by Type (2019-2024)
Figure 16. Market Size Market Share of New Drug Modeling Solution by Type in 2022
Figure 17. Global New Drug Modeling Solution Market Size Growth Rate by Type (2019-2024)
Figure 18. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 19. Global New Drug Modeling Solution Market Share by Application
Figure 20. Global New Drug Modeling Solution Market Share by Application (2019-2024)
Figure 21. Global New Drug Modeling Solution Market Share by Application in 2022
Figure 22. Global New Drug Modeling Solution Market Size Growth Rate by Application (2019-2024)
Figure 23. Global New Drug Modeling Solution Market Size Market Share by Region (2019-2024)
Figure 24. North America New Drug Modeling Solution Market Size and Growth Rate (2019-2024) & (M USD)
Figure 25. North America New Drug Modeling Solution Market Size Market Share by Country in 2023
Figure 26. U.S. New Drug Modeling Solution Market Size and Growth Rate (2019-2024) & (M USD)
Figure 27. Canada New Drug Modeling Solution Market Size (M USD) and Growth Rate (2019-2024)
Figure 28. Mexico New Drug Modeling Solution Market Size (Units) and Growth Rate (2019-2024)
Figure 29. Europe New Drug Modeling Solution Market Size and Growth Rate (2019-2024) & (M USD)
Figure 30. Europe New Drug Modeling Solution Market Size Market Share by Country in 2023
Figure 31. Germany New Drug Modeling Solution Market Size and Growth Rate (2019-2024) & (M USD)
Figure 32. France New Drug Modeling Solution Market Size and Growth Rate (2019-2024) & (M USD)
Figure 33. U.K. New Drug Modeling Solution Market Size and Growth Rate (2019-2024) & (M USD)
Figure 34. Italy New Drug Modeling Solution Market Size and Growth Rate (2019-2024) & (M USD)
Figure 35. Russia New Drug Modeling Solution Market Size and Growth Rate (2019-2024) & (M USD)
Figure 36. Asia Pacific New Drug Modeling Solution Market Size and Growth Rate (M USD)
Figure 37. Asia Pacific New Drug Modeling Solution Market Size Market Share by Region in 2023
Figure 38. China New Drug Modeling Solution Market Size and Growth Rate (2019-2024) & (M USD)
Figure 39. Japan New Drug Modeling Solution Market Size and Growth Rate (2019-2024) & (M USD)
Figure 40. South Korea New Drug Modeling Solution Market Size and Growth Rate (2019-2024) & (M USD)
Figure 41. India New Drug Modeling Solution Market Size and Growth Rate (2019-2024) & (M USD)
Figure 42. Southeast Asia New Drug Modeling Solution Market Size and Growth Rate (2019-2024) & (M USD)
Figure 43. South America New Drug Modeling Solution Market Size and Growth Rate (M USD)
Figure 44. South America New Drug Modeling Solution Market Size Market Share by Country in 2023
Figure 45. Brazil New Drug Modeling Solution Market Size and Growth Rate (2019-2024) & (M USD)
Figure 46. Argentina New Drug Modeling Solution Market Size and Growth Rate (2019-2024) & (M USD)
Figure 47. Columbia New Drug Modeling Solution Market Size and Growth Rate (2019-2024) & (M USD)
Figure 48. Middle East and Africa New Drug Modeling Solution Market Size and Growth Rate (M USD)
Figure 49. Middle East and Africa New Drug Modeling Solution Market Size Market Share by Region in 2023
Figure 50. Saudi Arabia New Drug Modeling Solution Market Size and Growth Rate (2019-2024) & (M USD)
Figure 51. UAE New Drug Modeling Solution Market Size and Growth Rate (2019-2024) & (M USD)
Figure 52. Egypt New Drug Modeling Solution Market Size and Growth Rate (2019-2024) & (M USD)
Figure 53. Nigeria New Drug Modeling Solution Market Size and Growth Rate (2019-2024) & (M USD)
Figure 54. South Africa New Drug Modeling Solution Market Size and Growth Rate (2019-2024) & (M USD)
Figure 55. Global New Drug Modeling Solution Market Size Forecast by Value (2019-2030) & (M USD)
Figure 56. Global New Drug Modeling Solution Market Share Forecast by Type (2025-2030)
Figure 57. Global New Drug Modeling Solution Market Share Forecast by Application (2025-2030)
Figure 1. Industrial Chain of New Drug Modeling Solution
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global New Drug Modeling Solution Market Size (M USD), 2019-2030
Figure 5. Global New Drug Modeling Solution Market Size (M USD) (2019-2030)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. New Drug Modeling Solution Market Size by Country (M USD)
Figure 10. Global New Drug Modeling Solution Revenue Share by Company in 2023
Figure 11. New Drug Modeling Solution Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 12. The Global 5 and 10 Largest Players: Market Share by New Drug Modeling Solution Revenue in 2023
Figure 13. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 14. Global New Drug Modeling Solution Market Share by Type
Figure 15. Market Size Share of New Drug Modeling Solution by Type (2019-2024)
Figure 16. Market Size Market Share of New Drug Modeling Solution by Type in 2022
Figure 17. Global New Drug Modeling Solution Market Size Growth Rate by Type (2019-2024)
Figure 18. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 19. Global New Drug Modeling Solution Market Share by Application
Figure 20. Global New Drug Modeling Solution Market Share by Application (2019-2024)
Figure 21. Global New Drug Modeling Solution Market Share by Application in 2022
Figure 22. Global New Drug Modeling Solution Market Size Growth Rate by Application (2019-2024)
Figure 23. Global New Drug Modeling Solution Market Size Market Share by Region (2019-2024)
Figure 24. North America New Drug Modeling Solution Market Size and Growth Rate (2019-2024) & (M USD)
Figure 25. North America New Drug Modeling Solution Market Size Market Share by Country in 2023
Figure 26. U.S. New Drug Modeling Solution Market Size and Growth Rate (2019-2024) & (M USD)
Figure 27. Canada New Drug Modeling Solution Market Size (M USD) and Growth Rate (2019-2024)
Figure 28. Mexico New Drug Modeling Solution Market Size (Units) and Growth Rate (2019-2024)
Figure 29. Europe New Drug Modeling Solution Market Size and Growth Rate (2019-2024) & (M USD)
Figure 30. Europe New Drug Modeling Solution Market Size Market Share by Country in 2023
Figure 31. Germany New Drug Modeling Solution Market Size and Growth Rate (2019-2024) & (M USD)
Figure 32. France New Drug Modeling Solution Market Size and Growth Rate (2019-2024) & (M USD)
Figure 33. U.K. New Drug Modeling Solution Market Size and Growth Rate (2019-2024) & (M USD)
Figure 34. Italy New Drug Modeling Solution Market Size and Growth Rate (2019-2024) & (M USD)
Figure 35. Russia New Drug Modeling Solution Market Size and Growth Rate (2019-2024) & (M USD)
Figure 36. Asia Pacific New Drug Modeling Solution Market Size and Growth Rate (M USD)
Figure 37. Asia Pacific New Drug Modeling Solution Market Size Market Share by Region in 2023
Figure 38. China New Drug Modeling Solution Market Size and Growth Rate (2019-2024) & (M USD)
Figure 39. Japan New Drug Modeling Solution Market Size and Growth Rate (2019-2024) & (M USD)
Figure 40. South Korea New Drug Modeling Solution Market Size and Growth Rate (2019-2024) & (M USD)
Figure 41. India New Drug Modeling Solution Market Size and Growth Rate (2019-2024) & (M USD)
Figure 42. Southeast Asia New Drug Modeling Solution Market Size and Growth Rate (2019-2024) & (M USD)
Figure 43. South America New Drug Modeling Solution Market Size and Growth Rate (M USD)
Figure 44. South America New Drug Modeling Solution Market Size Market Share by Country in 2023
Figure 45. Brazil New Drug Modeling Solution Market Size and Growth Rate (2019-2024) & (M USD)
Figure 46. Argentina New Drug Modeling Solution Market Size and Growth Rate (2019-2024) & (M USD)
Figure 47. Columbia New Drug Modeling Solution Market Size and Growth Rate (2019-2024) & (M USD)
Figure 48. Middle East and Africa New Drug Modeling Solution Market Size and Growth Rate (M USD)
Figure 49. Middle East and Africa New Drug Modeling Solution Market Size Market Share by Region in 2023
Figure 50. Saudi Arabia New Drug Modeling Solution Market Size and Growth Rate (2019-2024) & (M USD)
Figure 51. UAE New Drug Modeling Solution Market Size and Growth Rate (2019-2024) & (M USD)
Figure 52. Egypt New Drug Modeling Solution Market Size and Growth Rate (2019-2024) & (M USD)
Figure 53. Nigeria New Drug Modeling Solution Market Size and Growth Rate (2019-2024) & (M USD)
Figure 54. South Africa New Drug Modeling Solution Market Size and Growth Rate (2019-2024) & (M USD)
Figure 55. Global New Drug Modeling Solution Market Size Forecast by Value (2019-2030) & (M USD)
Figure 56. Global New Drug Modeling Solution Market Share Forecast by Type (2025-2030)
Figure 57. Global New Drug Modeling Solution Market Share Forecast by Application (2025-2030)
